• Vemurafenib (PLX4032): Multi-Omics Insights for Melanoma Res

  2026-05-09

  Explore how Vemurafenib (PLX4032) enables advanced melanoma research by integrating multi-omics findings and resistance mechanisms. This article uniquely connects molecular pharmacology with practical assay optimization and future therapeutic strategies.

• IEM 1460: Selective AMPA Receptor Blocker for Neuroprotectio

  2026-05-09

  IEM 1460 is a selective AMPA receptor blocker used in neuroscience research to dissect excitatory synaptic transmission and neuroprotection. This compound enables high-specificity modulation of glutamate signaling in excitotoxicity models. Its reliable performance in AMPA receptor inhibition assays supports advanced studies on synaptic plasticity and neurodegenerative mechanisms.

• Parathyroid hormone (1-34) (human) in Valvular Calcification

  2026-05-08

  Explore how Parathyroid hormone (1-34) (human) advances research into valvular calcification and endothelial-to-mesenchymal transition, offering unique insights into cardiovascular complications of chronic kidney disease. This article provides in-depth analysis and practical assay guidance for utilizing the PTH (1-34) peptide fragment.

• Bradykinin (BA5201): Protocols for Vascular and Inflammatory

  2026-05-07

  Bradykinin BA5201 is designed for experimental workflows requiring a potent endothelium-dependent vasodilator to study vascular permeability, smooth muscle contraction, and inflammation-related processes. Researchers should use this compound only in controlled laboratory settings, as it is not formulated for diagnostic or therapeutic use.

• E. coli Uracil-DNA Glycosylase (UDG): Lab Use & Protocols

  2026-05-07

  E. coli Uracil-DNA Glycosylase is designed for precise removal of uracil residues from DNA, supporting PCR contamination control and DNA damage repair research. This reagent is not suitable for RNA substrates, oligonucleotides under six bases, or any clinical or diagnostic purpose.

• CCCP for Mitochondrial Dysfunction: Precision Tools in AD Re

  2026-05-06

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is redefining mitochondrial assays through precise disruption of the proton gradient, enabling deep learning–powered biomarker discovery and live-cell phenotyping in Alzheimer's research. APExBIO’s rigorously characterized CCCP offers unmatched reproducibility and workflow flexibility for translational and mechanistic studies.

• Ertapenem Sodium Salt: Optimized Workflows for Resistance Re

  2026-05-06

  Ertapenem sodium salt streamlines high-fidelity resistance profiling and molecular epidemiology in Gram-positive and Gram-negative bacteria. This guide translates the latest findings on carbapenemase gene transmission into actionable protocols and troubleshooting strategies for the modern laboratory.

• RNA Pol II Inhibition Triggers Apoptosis Independent of Tran

  2026-05-05

  Harper et al. (2025) reveal that cell death after RNA polymerase II inhibition is not simply due to the passive loss of transcription, but rather to the active sensing and signaling of hypophosphorylated Pol II depletion, leading to apoptosis. This finding reframes how regulated cell death is understood in cancer research and highlights new experimental strategies for dissecting apoptotic signaling.

• Torin2: Precision mTOR Inhibitor Workflows for Cancer Resear

  2026-05-05

  Torin2 stands out as a next-generation mTOR inhibitor, offering unmatched potency and selectivity for dissecting PI3K/Akt/mTOR signaling in cancer research. This article delivers actionable protocols, advanced troubleshooting, and workflow innovations that leverage Torin2's unique properties—accelerating insights into regulated cell death and therapeutic resistance.

• Torin2 in Cancer Research: Quantitative Assay Design and mTO

  2026-05-04

  Explore how Torin2, a potent mTOR inhibitor, transforms quantitative assay design and cancer research. This article uncovers practical strategies, mechanistic depth, and new perspectives beyond standard workflows.

• Amyloid Beta-Peptide (1-40) (human): Beyond Plaques—Emerging

  2026-05-04

  Explore the novel biological functions of Amyloid Beta-Peptide (1-40) (human) in brain development and microglial regulation. This article offers advanced insights for Alzheimer’s disease research peptide applications, grounded in cutting-edge scientific evidence.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-05-03

  This study offers a detailed characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 pandemic, revealing high multidrug resistance and dominant plasmid-mediated blaNDM-1 dissemination. The work advances understanding of horizontal gene transfer and resistance epidemiology, informing both surveillance and experimental modeling.

• Benzyl-Activated Streptavidin Magnetic Beads (SKU: K1301) in

  2026-05-02

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for selective, reproducible capture of biotinylated molecules in protein, antibody, and nucleic acid workflows. This product is best suited for high-specificity applications such as immunoprecipitation assays, protein interaction studies, and advanced screening where low nonspecific binding is critical. Not recommended for non-biotinylated targets or workflows incompatible with hydrophobic bead surfaces.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Advancing Dual-Fluorescence

  2026-05-02

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables seamless, dual-fluorescence tracking of both mRNA delivery and translation with exceptional immune evasion. This APExBIO innovation bridges rapid optimization of nanoparticle carriers and robust protein expression readouts, streamlining next-generation gene delivery studies.

• Pharmacological and Clinical Profile of Palonosetron Hydroch

  2026-05-01

  This review summarizes a key reference study investigating the pharmacological selectivity, pharmacokinetics, and clinical performance of palonosetron hydrochloride as a 5-HT3 receptor antagonist for chemotherapy-induced and radiotherapy-induced nausea and vomiting (CINV/RINV). The study establishes its superior receptor selectivity and prolonged efficacy compared to prior agents, supporting its use in supportive cancer care.

16887 records 1/1126 page Next 12345 下5页 Last page